Leisure, Lifestyle & Wellness
Credit card-sized device lets patients analyse blood sample

It is simple to use: you switch it on by pressing a button, then apply your sample to a circle in the bottom right corner and wait for a digital reading to be displayed and even sent to your mobile phone

 

Patients suffering from kidney or heart diseases can avoid visiting hospitals for monitoring their disease status as researchers have now developed a pocket-friendly instrument. The credit card-sized device can analyse blood and saliva samples.
 
It is simple to use: you switch it on by pressing a button, then apply your sample to a circle in the bottom right corner and wait for a digital reading to be displayed and even sent to your mobile phone.
 
"The whole instrument is printed on the card using a screen-printing technique. It could be used to monitor diabetes, kidney disease and heart disease, or to detect cancer," said the researchers.
 
"Until now, we have been used to going to a doctor, who endows us with some wisdom and retains information about us, and then waiting to see, if we get better. Modern sensors and telecommunications are rebalancing this power; in the future, patients could have the information, while physicians provide a service," said Anthony Turner, professor at Linkoping University, Sweden.
 
According to Turner, who has developed the instrument, the new machine could turn a 2,500-year-old paradigm on its head and put the power in the patient's hands.
 
"We are on the cusp of an entirely new era -- not just for bio-sensing, but for measurements in healthcare and diagnostics generally," Turner noted.
 
Bio-sensors can detect and analyze data to give patients information on their heart rate and blood pressure, blood sugar and hormone levels, and even test whether they are infected with antibiotic-resistant bacteria.
 
This detection technology is a step forward in personal medicine, giving patients real-time information about how their bodies are functioning and suggesting the most suitable treatments.
 
The printed instruments are the result of a collaboration between Linkoping University and Swedish ICT non-profit Acreo, and the team is now looking for corporate partners to work with to mass-produce them.
 
The findings were presented at Elsevier's fourth international conference on Bio-Sensing Technology in Lisbon, Portugal on Tuesday.

User

Cabinet approves stake sale in Indian Oil, NTPC

The proposed sale of 5 percent stake in NTPC is expected to fetch the exchequer around Rs.5,500 crore, while that of 10 percent stake in IOC would bring in nearly Rs.8000 crore

 

The union cabinet on Wednesday approved the sale of a 10 percent stake in Indian Oil Corp and a 5 percent stake in NTPC, a government source said here.
 
The proposed sale of 5 percent stake in NTPC is expected to fetch the exchequer around Rs.5,500 crore, while that of 10 percent stake in IOC would bring in nearly Rs.8000 crore.
 
As per stock exchange data, the government holds 74.96 percent stake in NTPC and 68.57 percent in IOC.
 
It has an ambitious disinvestment target of Rs.41,000 crore through stake sale in public sector units, and another Rs.28,500 crore through strategic stake sale by transfer of management control, during the current fiscal.
 
The IOC stake sale, that was put off last year, was taken up by the government after international crude oil prices began to rise and there was more clarity on subsidy sharing.
 
As on Wednesday, the market capitalisation of NTPC stood at Rs.111,313.77 crore while that of IOC was Rs.79,321.21 crore.

User

Monsoon, global financial volatility pose risk to India: Moody's

The rating agency attributed the current subdued growth conditions on weak domestic credit conditions, tepid domestic demand and uncertain global growth

 

The monsoon and global financial volatility will pose additional risk to India's growth this year besides weak domestic credit conditions and tepid domestic demand, rating agency Moody's said on Wednesday.
 
Nonetheless, looking ahead to the next 18 to 24 months, Moody's said India's growth was likely to average around 7.5 percent.
 
The rating agency attributed the current subdued growth conditions on weak domestic credit conditions, tepid domestic demand and uncertain global growth.
 
"Since India's structural reform efforts will revive domestic investment and competitiveness over the medium - rather than near - term, the above factors will limit the pace of economic recovery in India over the next two quarters, while the monsoon and the potential for global financial volatility pose additional risks to growth this year," a report by Moody's Investor Service said.
 
The rating agency said the growth forecast was supported by India's structural advantages as well as by recent and planned improvements to its operating environment.
 
India's structural advantages include favourable demographics, a large economy - which offers investment opportunities - and economic diversity, as well as high savings and investment rates, the report said.
 
The report, however, said that the extent to which India's growth will outperform -- and for how long growth will remain high -- will depend on how infrastructure, regulatory and bureaucratic reforms are implemented "given that these measures are still at the early stages of design".
 
The recent reform efforts included the inflation targeting framework; regulatory simplification; and increase in limits for foreign direct investment in rail infrastructure and defence and insurance sectors.
 
It also included higher levels of public infrastructure investment; measures to promote financial savings; bills relating to mining; and measures to reduce banking system risk, such as counter-cyclical buffer requirements and liquidity coverage guidance.
 
Moody's also pointed out that even with robust growth, India's fiscal metrics are likely to remain weaker than those of similarly rated peers, and the social, political and economic challenges associated with low average incomes will persist over the medium term.

User

We are listening!

Solve the equation and enter in the Captcha field.
  Loading...
Close

To continue


Please
Sign Up or Sign In
with

Email
Close

To continue


Please
Sign Up or Sign In
with

Email

BUY NOW

The Scam
24 Year Of The Scam: The Perennial Bestseller, reads like a Thriller!
Moneylife Magazine
Fiercely independent and pro-consumer information on personal finance
Stockletters in 3 Flavours
Outstanding research that beats mutual funds year after year
MAS: Complete Online Financial Advisory
(Includes Moneylife Magazine and Lion Stockletter)